Your browser doesn't support javascript.
loading
Hyperglycemia and blood glucose deterioration are risk factors for severe COVID-19 with diabetes: A two-center cohort study.
Xiao, Fen; Zhou, Ying-Chu; Zhang, Mei-Biao; Chen, Dong; Peng, Shao-Lin; Tang, Hao-Neng; Li, Long; Tang, Chen-Yi; Liu, Ji-Yang; Li, Bo; Zhou, Hou-De.
Afiliación
  • Xiao F; National Clinical Research Center for Metabolic Diseases, Hunan Provincial Key Laboratory for Metabolic Bone Diseases, and Department of Metabolism and Endocrinology, The Second Xiangya Hospital of Central South University, Changsha, Hunan, China.
  • Zhou YC; The First Hospital of Changsha, The Hospital of Infectious Diseases of Changsha, The Public Health Treatment Center of Changsha, Changsha, Hunan, China.
  • Zhang MB; The First People's Hospital of Huaihua, Huaihua, Hunan, China.
  • Chen D; The First Hospital of Changsha, The Hospital of Infectious Diseases of Changsha, The Public Health Treatment Center of Changsha, Changsha, Hunan, China.
  • Peng SL; The First People's Hospital of Huaihua, Huaihua, Hunan, China.
  • Tang HN; National Clinical Research Center for Metabolic Diseases, Hunan Provincial Key Laboratory for Metabolic Bone Diseases, and Department of Metabolism and Endocrinology, The Second Xiangya Hospital of Central South University, Changsha, Hunan, China.
  • Li L; National Clinical Research Center for Metabolic Diseases, Hunan Provincial Key Laboratory for Metabolic Bone Diseases, and Department of Metabolism and Endocrinology, The Second Xiangya Hospital of Central South University, Changsha, Hunan, China.
  • Tang CY; National Clinical Research Center for Metabolic Diseases, Hunan Provincial Key Laboratory for Metabolic Bone Diseases, and Department of Metabolism and Endocrinology, The Second Xiangya Hospital of Central South University, Changsha, Hunan, China.
  • Liu JY; The First Hospital of Changsha, The Hospital of Infectious Diseases of Changsha, The Public Health Treatment Center of Changsha, Changsha, Hunan, China.
  • Li B; The First Hospital of Changsha, The Hospital of Infectious Diseases of Changsha, The Public Health Treatment Center of Changsha, Changsha, Hunan, China.
  • Zhou HD; National Clinical Research Center for Metabolic Diseases, Hunan Provincial Key Laboratory for Metabolic Bone Diseases, and Department of Metabolism and Endocrinology, The Second Xiangya Hospital of Central South University, Changsha, Hunan, China.
J Med Virol ; 94(5): 1967-1975, 2022 05.
Article en En | MEDLINE | ID: mdl-34967028
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Diabetes Mellitus / COVID-19 / Hiperglucemia Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: J Med Virol Año: 2022 Tipo del documento: Article País de afiliación: China Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Diabetes Mellitus / COVID-19 / Hiperglucemia Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: J Med Virol Año: 2022 Tipo del documento: Article País de afiliación: China Pais de publicación: Estados Unidos